|
|
| | Lesinurad Impurity K Basic information |
| Product Name: | Lesinurad Impurity K | | Synonyms: | Lesinurad Impurity K;Lesinurad Impurity 4/ 2-[[5-Bromo-4-(4-propylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetic acid;2-((5-bromo-4-(4-propylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid;Acetic acid, 2-[[5-bromo-4-(4-propyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]- | | CAS: | 1533519-96-8 | | MF: | C17H16BrN3O2S | | MW: | 406.3 | | EINECS: | 604-604-1 | | Product Categories: | | | Mol File: | 1533519-96-8.mol |  |
| | Lesinurad Impurity K Chemical Properties |
| Boiling point | 619.8±65.0 °C(Predicted) | | density | 1.55±0.1 g/cm3(Predicted) | | pka | 2.91±0.10(Predicted) |
| | Lesinurad Impurity K Usage And Synthesis |
| Uses | 2-[[5-Bromo-4-(4-propyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid is an impurity of drug Lesinurad (L329700), which is used to synthesize febuxostat which is a non-purine analog inhibitor of xanthine oxidase. Febuxostat is approved by the European Medicines Agency and the US Food and Drug Administration for treating gout. |
| | Lesinurad Impurity K Preparation Products And Raw materials |
|